Quick Takeaways
- JPMORGAN CHASE & CO filed SCHEDULE 13G for SIONNA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (SION).
- Disclosed ownership: 5%.
- Date of event: 30 Jun 2025.
JPMORGAN CHASE & CO - 30 Jun 2025 SCHEDULE 13G Report for SIONNA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (SION)
- Filing Manager
- JPMORGAN CHASE & CO
- Reporting Manager
- JPMORGAN CHASE & CO.
- Symbol
- SION
- Shares outstanding
- 44,423,760 shares
- Disclosed Ownership
- 2,221,188 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 30 Jul 2025, 13:19:42 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 31 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JPMORGAN CHASE & CO disclosed 5% ownership in SIONNA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (SION) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Jul 2025, 13:19.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO. | 5% | 2,221,188 | 1,978,546 | 0 | Rachel Tsvaygoft | Vice President |